Publications by authors named "Michelle McGovern"

Claim this Profile
U
Ultrasound-Enhancing Agents and Associated Adverse Reactions: A Potential Connection to the COVID-19 Vaccines?
Meshal Soni, Michelle McGovern, Ron Jacob, Richard Weiss, Srinath Adusumalli

J Am Soc Echocardiogr· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis.
Sabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, Newman Knowlton, Eric A Macklin, Michelle McGovern

Muscle Nerve· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis.
Sabrina Paganoni, Eric A Macklin, Suzanne Hendrix, James D Berry, Michael A Elliott, Michelle McGovern

N Engl J Med· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recruitment & retention program for the NeuroNEXT SMA Biomarker Study: Super Babies for SMA!
Amy Bartlett, Stephen J Kolb, Allison Kingsley, Kathryn J Swoboda, Sandra P Reyna, Michelle M McGovern

Contemp Clin Trials Commun· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.
Robert J Fox, Christopher S Coffey, Robin Conwit, Merit E Cudkowicz, Trevis Gleason, Michelle McGovern

N Engl J Med· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural history of infantile-onset spinal muscular atrophy.
Stephen J Kolb, Christopher S Coffey, Jon W Yankey, Kristin Krosschell, W David Arnold, Michelle M McGovern, Vicki L McGovern

Ann Neurol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.
Robert J Fox, Christopher S Coffey, Merit E Cudkowicz, Trevis Gleason, Andrew Goodman, Michelle McGovern

Contemp Clin Trials· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study.
Stephen J Kolb, Christopher S Coffey, Jon W Yankey, Kristin Krosschell, W David Arnold, Michelle M McGovern, Vicki L McGovern

Ann Clin Transl Neurol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proceed with caution: is making a disclosure under the self-referral disclosure protocol worth the risk?
Michelle McGovern

Health Care Law Mon· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis